Cat.#: ACPP-1311
Despition | Leukemia Inhibitory Factor Human Recombinant |
SIZE | 3 x 2 µg |
Purity | > 98.0% (SDS-PAGE) |
Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored and desiccated below -18°C. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1320 | FGFR4 Blocking Peptide (AC1320) | 250 µg | inquiry |
ACPP-1777 | Human Acrp30 Protein (AC1777) | 5 µg | inquiry |
ACPP-1343 | GIRK1 Blocking Peptide (AC1343) | 250 µg | inquiry |
ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
ACPP-1225 | POMT1 Blocking Peptide (AC1225) | 250 µg | inquiry |
ACPP-1194 | Calcium Sensing Receptor Blocking Peptide (AC1194) | 250 µg | inquiry |
ACPP-1470 | Human CLTA Protein (AC1470) | 5 µg | inquiry |
ACPP-1247 | GSK3 beta Blocking Peptide (AC1247) | 250 µg | inquiry |
ACPP-1069 | Calretinin Blocking Peptide (AC1069) | 250 µg | inquiry |
ACPP-1154 | Recombinant Human FGF19 Protein (6×His Tag) (AC1154) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.